We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
When the FDA talks, pharma listens. But what happens when the FDA talks way more than usual? We're finding out now, thanks to FDA Commissioner Scott Gottlieb and his torrent of public statements.